Answer
Pegaspargase (Oncaspar) should not be used during pregnancy unless the woman’s clinical condition requires treatment with pegaspargase; there are no data on Oncaspar use in pregnant women.
Sources for this answer
- Oncaspar 750 U/ml powder for solution for injection/infusionServier Laboratories Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 8Document updated
Sources checked